AstraZeneca says 'no evidence' linking vaccine to clots after multiple countries pause rollout

AstraZeneca defended the safety of its coronavirus vaccine in an unusual statement Sunday after reports emerged of abnormal blood clots in some immunized patients in Norway and in Demark.